Category: by reason for retraction

A former postdoc at the University of Michigan admitted to research misconduct, but lied about how extensive it was, according to a new finding by the U.S. Office of Research Integrity (ORI).

The ORI doesn’t describe Venkata Sudheer Kumar Ramadugu‘s misconduct — that detail will likely come later in the Federal Register, according to their relatively new practice [see update below] — but says that as a postdoc in Michigan’s department of chemistry he “engaged in research misconduct” in work supported by two NIH grants.

Ramadugu agreed to a five-year ban on Federal funding. The penalty was that severe, according to ORI’s annoucement, because Ramadugu Continue reading Former UMich postdoc earns five-year ban on Federal funding, after admitting to misconduct and then lying

A former researcher at Cedars-Sinai Medical Center has been sanctioned by a Federal watchdog for misconduct in a 2017 paper that claimed to link food preservatives and obesity.

Uthra Rajamani, first author of the paper in Nature Communications, “engaged in research misconduct,” according to the U.S. Office of Research Integrity (ORI), and agreed to have any Federally funded research supervised for a year. She also agreed to request the retraction of the paper in question.

The ORI announcement does not specify the type of misconduct Rajamani committed, but refers to an upcoming Federal Register notice that, if past history is any indication, should contain those details. [See update at end of post.] In a statement to Retraction Watch, Cedars-Sinai said: Continue reading Former Cedars-Sinai scientist committed misconduct in food preservatives-obesity paper

The U.S. Office of Research Integrity has announced findings of misconduct against a once-promising pharmaceutical scientist at the University of Colorado.

The ORI says Rajendra Kadam fabricated data on government grants while working on his PhD at UC Denver under the supervision of Uday Kompella. As we reported in 2015 when this case first broke, Kadam was put in charge of a piece of technology that apparently he alone knew how to operate — giving him ample opportunity to cook results without fear of detection.

Under the terms of the ORI finding — which comes nearly four years after the UC inquiry wrapped up — Kadam will be barred from Federal U.S. research funding for three years, beginning November 13, 2018. Continue reading Former Colorado “golden boy” earns three-year ban on Federal funding

Last month, a judge recommended that a former University of Kansas Medical Center professor be banned from Federal U.S. funding for two years. The ban came after an investigation showed that the researcher, Rakesh Srivastava, had submitted a grant application that was heavily plagiarized from someone else’s. But there’s far more to the case, as Richard Goldstein –who represented the scientist in Bois v. HHS, the first case to overturn a funding ban by the U.S. Office of Research Integrity (ORI), and who has written about another case for us — argues in this guest post. 

Picture this scenario: You submit an NIH grant proposal.  Unbeknownst to you, it contains material plagiarized from another scientist.  Are you liable for research misconduct? Continue reading A colleague included plagiarized material in your grant proposal. Are you liable?